14.
INCOME TAXES

Deferred income taxes consist of the following as of December 31, 2025 and 2024 (in thousands):

 

 

As of December 31,

 

 

2025

 

 

2024

 

Deferred Income Tax Assets:

 

 

 

 

 

Net Operating Loss Carryforwards

$

402,347

 

 

$

308,669

 

IRC §163(j) Interest Expense Limitation Carryover

 

35,875

 

 

 

29,239

 

Lease Liability

 

22,629

 

 

 

7,997

 

Research and Development

 

210,273

 

 

 

118,649

 

Excess of Tax Basis over Book Basis Fixed Assets

 

 

 

 

4,696

 

Deferred Revenue

 

8,858

 

 

 

19,708

 

Revenue Reserve Liability

 

2,742

 

 

 

2,812

 

Stock Compensation

 

27,273

 

 

 

26,441

 

Other

 

17,304

 

 

 

1,077

 

 

$

727,301

 

 

$

519,288

 

Less Valuation Allowance

 

(599,846

)

 

 

(503,071

)

 

$

127,455

 

 

$

16,217

 

Deferred Income Tax Liabilities:

 

 

 

 

 

Excess of book basis over tax basis fixed assets

 

(720

)

 

 

 

Unrealized Gain/Loss on Marketable Equity Securities

 

(22,725

)

 

 

(3,878

)

Right of Use Asset

 

(16,655

)

 

 

(3,615

)

Warrant Contract Asset

 

 

 

 

(7,697

)

Intangible assets

 

(85,667

)

 

 

 

Other

 

(2,018

)

 

 

(1,261

)

 

$

(127,785

)

 

$

(16,451

)

Net Deferred Income Tax Liability

$

(330

)

 

$

(234

)

 

The provision for income taxes consists of the following for the years ended December 31, 2025, 2024 and 2023 (in thousands):

 

 

Year Ended December 31,

 

 

2025

 

 

2024

 

 

2023

 

Current tax expense (benefit)

 

 

 

 

 

 

 

 

Federal

 

 

 

 

 

 

 

 

State

 

395

 

 

 

(33

)

 

 

13

 

Foreign

 

490

 

 

 

188

 

 

 

152

 

Total

$

885

 

 

$

155

 

 

$

165

 

Deferred tax (benefit) expense

 

 

 

 

 

 

 

 

Federal

 

(39,033

)

 

 

93

 

 

 

108

 

State

 

(13,536

)

 

 

18

 

 

 

15

 

Foreign

 

 

 

 

 

 

 

 

Total

 

(52,569

)

 

 

111

 

 

 

123

 

Total tax (benefit) expense

 

 

 

 

 

 

 

 

Federal

 

(39,033

)

 

 

93

 

 

 

108

 

State

 

(13,141

)

 

 

(15

)

 

 

28

 

Foreign

 

490

 

 

 

188

 

 

 

152

 

Total income tax (benefit) expense

$

(51,684

)

 

$

266

 

 

$

288

 

 

The components of income before income taxes as follows (in thousands):

 

 

Year Ended December 31,

 

 

2025

 

 

2024

 

 

2023

 

Domestic

$

(290,382

)

 

$

(701,648

)

 

$

(213,522

)

Foreign

 

(718

)

 

 

339

 

 

 

(243

)

 

A reconciliation of the difference between the federal statutory rate and the effective income tax rate as a percentage of income before taxes for the year ended December 31, 2025 was as follows:

 

 

December 31, 2025

 

 

Amount

 

 

Percent

 

Federal statutory

$

(61,131

)

 

 

21.00

%

 

 

 

 

 

 

Nontaxable or nondeductible items

 

 

 

 

 

Stock compensation

 

(67,177

)

 

 

23.08

%

Officer compensation

 

64,387

 

 

 

(22.12

%)

Other nontaxable or nondeductible items

 

2,514

 

 

 

(0.86

%)

Changes in valuation allowances

 

21,331

 

 

 

(7.33

%)

Other

 

978

 

 

 

(0.33

%)

State and local income taxes, net of federal income tax effect

 

(15,900

)

 

 

5.46

%

Foreign tax effects

 

 

 

 

 

Other foreign jurisdictions

 

638

 

 

 

(0.22

%)

Worldwide changes in unrecognized tax benefits

 

2,676

 

 

 

(0.92

%)

Effective tax rate

$

(51,684

)

 

 

17.76

%

 

The states that contribute to the majority (greater than 50%) of the tax effect in this category include California, Illinois, Maryland, and Pennsylvania.

A reconciliation of the difference between the federal statutory rate and the effective income tax rate as a percentage of income before taxes for the years ended December 31, 2024 and 2023:

 

 

Year Ended December 31,

 

2024

 

2023

Federal statutory tax rate

21.00%

 

21.00%

State statutory tax rate

4.35%

 

3.28%

Foreign

0.00%

 

(0.09%)

Stock compensation

5.60%

 

0.00%

Officer compensation

(1.46%)

 

0.00%

Other permanent differences

(0.17%)

 

0.47%

Other

(0.02%)

 

(0.06%)

Change in valuation allowance

(29.34%)

 

(24.74%)

Total

(0.04%)

 

(0.14%)

 

Net change in valuation allowance was as follows (in thousands):

 

 

Year Ended December 31,

 

 

2025

 

 

2024

 

 

2023

 

Valuation Allowance, beginning of year

$

503,071

 

 

$

297,294

 

 

$

244,064

 

Changes

 

10,764

 

 

 

205,777

 

 

 

52,878

 

Purchase accounting adjustments

 

86,011

 

 

 

 

 

 

352

 

Valuation Allowance, end of year

$

599,846

 

 

$

503,071

 

 

$

297,294

 

 

For the years ended December 31, 2025 and 2024, the Company recognized income tax benefit on stock-based compensation of $83.1 million and $46.2 million, respectively (tax-effected).

For the year ended December 31, 2025, cash paid for income taxes, net of refunds received, by jurisdiction was as follows:

 

 

December 31, 2025

 

U.S. federal

$

(91

)

U.S. state and local

 

 

Pennsylvania

 

77

 

Washington

 

118

 

Other

 

47

 

Non-U.S.

 

 

France

 

40

 

Spain

 

166

 

Canada

 

297

 

Total worldwide taxes paid

$

654

 

The Company’s income tax expense as recorded in the financial statements differs from the benefit computed by applying statutory tax rates to net loss before income taxes due to permanent differences related to the deductibility of certain expenses and the valuation allowance. Due to the acquisition of Ambry during the year ended December 31, 2025, the existing valuation allowance decreased for the establishment of the deferred tax liabilities. Current income tax expense for the years ended December 31, 2025, 2024 and 2023, related to state and foreign expense was not material.

As of December 31, 2025 the Company had federal net operating loss (“NOL”) carry forwards of $332.8 million (tax effected) and state NOL carry forwards of approximately $69.6 million (tax effected), which may be available to offset future taxable income. The federal NOLs will begin to expire in 2037 and the state NOLs will begin to expire in 2028.

As of December 31, 2025, the Company had federal and state credit carry forwards of $11.6 million, which may be able to offset future tax expense. The credits will begin to expire in 2039. A full valuation allowance has been recorded against the NOL and credit carry forwards.

The Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. Due to its operating loss carryforwards, the U.S. federal statute of limitations remains open for tax year 2016 and onward and the Company continues to be subject to examination by the Internal Revenue Service for tax years 2016 and later. The resolutions of any examinations are not expected to be material to these financial statements. As of December 31, 2025 and 2024, there are no penalties or accrued interest recorded in the consolidated financial statements. The calculation of the Company’s tax obligations involves dealing with uncertainties in the application of complex tax laws and regulations. ASC 740, Income Taxes, provides that a tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, on the basis of the technical merits. The Company has assessed its income tax positions and recorded tax benefits for all years subject to examination, based upon its evaluation of the facts, circumstances and information available at each period end. For those tax positions where the Company has determined there is a greater than 50% likelihood that a tax benefit will be sustained, the Company has recorded the largest amount of tax benefit that may potentially be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where it is determined there is less than 50% likelihood that a tax benefit will be sustained, no tax benefit has been recognized.

A reconciliation of the Company's gross change in unrecognized tax benefits ("UTBs"), including accrued interest and penalties, for the years ended December 31, 2025, 2024 and 2023 was as follows:

 

 

Year Ended December 31,

 

 

2025

 

 

2024

 

 

2023

 

Unrecognized tax benefits—beginning of year

$

 

 

$

 

 

$

 

Gross additions—current year tax positions

 

 

 

 

 

 

 

 

Gross additions—prior year tax positions

 

2,676

 

 

 

 

 

 

 

Gross additions—acquired in business combinations

 

2,450

 

 

 

 

 

 

 

Gross reductions—prior year tax positions

 

 

 

 

 

 

 

 

Gross reductions—settlements with taxing authorities

 

 

 

 

 

 

 

 

Gross reductions—statute lapses

 

 

 

 

 

 

 

 

Unrecognized tax benefits—end of year

$

5,126

 

 

$

 

 

$

 

Unrecognized tax benefits—accrued interest and penalties

 

 

 

 

 

 

 

 

Gross unrecognized tax benefits

$

5,126

 

 

$

 

 

$

 

 

Of the $5.1 million unrecognized tax benefits as of December 31, 2025, all are recorded as a net offset to deferred income taxes in our consolidated financial statements. If recognized, none of the unrecognized tax benefits as of December 31, 2025 would impact our effective tax rate.

The Company recognizes interest and, if applicable, penalties for any uncertain tax positions. Interest and penalties are recorded as a component of income tax expense. In the years ended December 31, 2025, 2024 and 2023, the Company did not have any accrued interest or penalties associated with any unrecognized tax benefits.

The Company does not provide for U.S. income taxes on unremitted earnings of foreign subsidiaries. Unremitted earnings of foreign subsidiaries were immaterial on December 31, 2025 and 2024.

One Big Beautiful Bill Act

On July 4, 2025, the One Big Beautiful Bill Act (the “Act”) was enacted into law in the U.S. The Act includes significant provisions, such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act, modifications to the international tax framework and the restoration of favorable tax treatment for certain business provisions. The legislation has multiple effective dates, with certain provisions effective in 2025 and others implemented through 2027. The Company has evaluated the impact of the Act on deferred tax assets and liabilities, including adjustments to valuation allowances, and has reflected these effects in the consolidated financial statements.

Historical Timeline

Fiscal YearFiled
2025Feb 24, 2026Showing above
2024Feb 24, 2025

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.